GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anti-Microbial Savior BioteQ Co Ltd (ROCO:6864) » Definitions » EPS without NRI

Anti-Microbialvior BioteQ Co (ROCO:6864) EPS without NRI : NT$-2.46 (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Anti-Microbialvior BioteQ Co EPS without NRI?

Anti-Microbialvior BioteQ Co's earnings per share without non-recurring items for the six months ended in Dec. 2024 was NT$-1.36. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.46.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -27.80% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -14.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Anti-Microbialvior BioteQ Co's EPS without NRI or its related term are showing as below:

ROCO:6864' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -27.8   Med: -8.4   Max: -4
Current: -27.8

During the past 7 years, Anti-Microbialvior BioteQ Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was -4.00% per year. The lowest was -27.80% per year. And the median was -8.40% per year.

ROCO:6864's 3-Year EPS without NRI Growth Rate is ranked worse than
85.24% of 1233 companies
in the Biotechnology industry
Industry Median: 10.5 vs ROCO:6864: -27.80

Anti-Microbialvior BioteQ Co's EPS (Diluted) for the six months ended in Dec. 2024 was NT$-1.36. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.46.

Anti-Microbialvior BioteQ Co's EPS (Basic) for the six months ended in Dec. 2024 was NT$-1.36. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$-2.46.


Anti-Microbialvior BioteQ Co EPS without NRI Historical Data

The historical data trend for Anti-Microbialvior BioteQ Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anti-Microbialvior BioteQ Co EPS without NRI Chart

Anti-Microbialvior BioteQ Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EPS without NRI
Get a 7-Day Free Trial -1.63 -1.18 -1.26 -2.07 -2.46

Anti-Microbialvior BioteQ Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.76 -0.81 -1.26 -1.10 -1.36

Competitive Comparison of Anti-Microbialvior BioteQ Co's EPS without NRI

For the Biotechnology subindustry, Anti-Microbialvior BioteQ Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anti-Microbialvior BioteQ Co's PE Ratio without NRI Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anti-Microbialvior BioteQ Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Anti-Microbialvior BioteQ Co's PE Ratio without NRI falls into.


;
;

Anti-Microbialvior BioteQ Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$-2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Anti-Microbialvior BioteQ Co  (ROCO:6864) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Anti-Microbialvior BioteQ Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of Anti-Microbialvior BioteQ Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Anti-Microbialvior BioteQ Co Business Description

Traded in Other Exchanges
N/A
Address
No. 6, Siwei 3rd Road, 7th Floor-2, Lingya District, Kaohsiung, TWN, 741
Anti-Microbial Savior BioteQ Co Ltd is engaged in drug research and development as well as development and technology patenting of medical fungi.

Anti-Microbialvior BioteQ Co Headlines

No Headlines